Intellia Therapeutics, Inc. (NTLA)
10.55
-0.86
(-7.54%)
USD |
NASDAQ |
Nov 12, 16:00
10.79
+0.24
(+2.27%)
After-Hours: 06:22
Intellia Therapeutics Price to Book Value : 2.414 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.414 |
| November 11, 2026 | 2.610 |
| November 10, 2026 | 2.555 |
| November 09, 2026 | 2.770 |
| November 06, 2026 | 2.596 |
| November 05, 2026 | 2.539 |
| November 04, 2026 | 2.816 |
| November 03, 2026 | 2.713 |
| November 02, 2026 | 2.667 |
| October 30, 2026 | 2.853 |
| October 29, 2026 | 3.027 |
| October 28, 2026 | 3.047 |
| October 27, 2026 | 2.809 |
| October 26, 2026 | 2.576 |
| October 23, 2026 | 2.564 |
| October 22, 2026 | 2.553 |
| October 21, 2026 | 2.665 |
| October 20, 2026 | 2.709 |
| October 19, 2026 | 2.649 |
| October 16, 2026 | 2.612 |
| October 15, 2026 | 2.594 |
| October 14, 2026 | 2.615 |
| October 13, 2026 | 2.725 |
| October 12, 2026 | 2.878 |
| October 09, 2026 | 2.99 |
| Date | Value |
|---|---|
| October 08, 2026 | 2.882 |
| October 07, 2026 | 2.679 |
| October 06, 2026 | 2.830 |
| October 05, 2026 | 2.917 |
| October 02, 2026 | 2.805 |
| October 01, 2026 | 2.773 |
| September 30, 2026 | 2.759 |
| September 29, 2026 | 2.315 |
| September 28, 2026 | 2.197 |
| September 25, 2026 | 2.261 |
| September 24, 2026 | 2.340 |
| September 23, 2026 | 2.372 |
| September 22, 2026 | 2.442 |
| September 21, 2026 | 2.351 |
| September 18, 2026 | 2.336 |
| September 17, 2026 | 2.359 |
| September 16, 2026 | 2.211 |
| September 15, 2026 | 2.186 |
| September 14, 2026 | 2.284 |
| September 11, 2026 | 2.259 |
| September 10, 2026 | 2.296 |
| September 09, 2026 | 2.349 |
| September 08, 2026 | 2.451 |
| September 04, 2026 | 2.451 |
| September 03, 2026 | 2.440 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 16.06 |
| Beam Therapeutics, Inc. | 2.609 |
| Prime Medicine, Inc. | 17.66 |
| 10X Genomics, Inc. | 9.273 |
| Moderna, Inc. | 13.67 |
Price to Book Value Related Metrics
| PS Ratio | 25.34 |
| Price | 10.55 |
| Earnings Yield | -31.72% |
| Market Cap | 1.480B |